1. DISEASE CHARACTERISTICS 1.1 Name of the disease (synonyms) Phelan-McDermid syndrome/22q13 deletion syndrome/chromosome 22q13.3 deletion syndrome/telomeric 22q13 monosomy syndrome.
1.2 OMIM# of the disease 606232.
1.3 Name of the analysed genes or DNA/chromosome segments SHANK3, 22q13.3.
OMIM# of the gene(s)
602306.
Mutational spectrum
Phelan-McDermid syndrome can result from simple 22q13 deletions, ring chromosomes and unbalanced translocations. [1] [2] [3] [4] [5] The deletions are extremely variable in size, ranging from 95 kb to 9 Mb. The gene responsible for the core neurological features is SHANK3, which has been found to be mutated in patients with autism spectrum disorders and intellectual disability. [6] [7] [8] [9] 55% de novo deletion 22q13.3 of the paternally derived chromosome 20% de novo deletion 22q13.3 of the maternally derived chromosome 10% paternal structural rearrangement 10% maternal structural rearrangement 4% de novo unbalanced rearrangement o1% mutations within SHANK3 gene (only a small number of studies have sequenced SHANK3, so the frequency may be underestimated). [6] [7] [8] [9] [10] Deletions of 22q13, not including the SHANK3 gene, have been reported in two unrelated individuals with Phelan-McDermid syndrome. 11
Analytical methods
Chromosome analysis, FISH, array CGH, MLPA and DNA sequencing. Conventional cytogenetics is usually normal except for cases resulting from unbalanced translocations (24%). Small terminal or interstitial deletions of 22q13 will not be detected by FISH unless this region of chromosome 22 is targeted by probes specific for SHANK3 or other loci within the deleted region.
Analytical validation
Parallel analysis of positive and negative controls, depending on analytical method.
1.8 Estimated frequency of the disease (incidence at birth ('birth prevalence') or population prevalence) Unknown due to underdiagnosis.
1.9 If applicable, prevalence in the ethnic group of investigated person Not applicable.
Diagnostic setting

Comment:
In 20% of cases, deletion 22q13 results from a structural rearrangement in one of the parents. Study of the parents allows determination of whether additional family members are at risk of being balanced carriers. Detection of an inherited rearrangement may also influence the family's interest in prenatal diagnosis.
TEST CHARACTERISTICS
2.1 Analytical sensitivity (proportion of positive tests if the genotype is present) Nearly 100%.
Analytical specificity (proportion of negative tests if the genotype is not present)
Nearly 100%.
Clinical sensitivity (proportion of positive tests if the disease is present)
The clinical sensitivity can be dependent on variable factors such as age or family history. In such cases, a general statement should be given, even if a quantification can only be made case by case. Nearly 100%. This may vary in the presence of mosaicism for the deletion of chromosome 22.
Clinical specificity (proportion of negative tests if the disease is not present)
The clinical specificity can be dependent on variable factors such as age or family history. In such cases, a general statement should be given, even if a quantification can only be made case by case.
Nearly 100%. 
Genetic risk assessment in family members of a diseased person
(To be answered if in 1.10 'C' was marked)
Does the result of a genetic test resolve the genetic situation in that family?
Yes. Establishing whether the deletion is de novo or secondary to a chromosomal rearrangement in one of the parents will influence the need for genetic testing in other family members.
Can a genetic test in the index patient save genetic or other tests in family members?
Yes. Knowing whether the deletion is de novo or secondary to a familial translocation has direct consequences for the genetic counselling of relatives.
Does a positive genetic test result in the index patient enable a predictive test in a family member?
Yes. Prenatal testing is an option for family members who are carriers of a balanced rearrangement. useful to relatives in the presence of a structural abnormality that might be inherited.
Prenatal diagnosis
IF APPLICABLE, FURTHER CONSEQUENCES OF TESTING
